BeStock  
Markets › Compare › ELAN vs NBIX

ELAN vs NBIX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ELAN · Elanco Animal Health$25.74 ▼ 2.09%
NBIX · Neurocrine Biosciences$150.57 ▼ 3.84%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8396109121134Nov 24, '25May 26, '26Nov 20, '26
  • ELAN +11.5%
  • NBIX +6.6%

Head to head

MetricELANNBIX
Price$25.74$150.57
Change today▼ 2.09%▼ 3.84%
Market cap$12.87B$15.24B
Return, 3 months+5.4%-1.6%
Return, year to date+13.7%+6.2%
Return, 1 year+15.7%+6.2%
P/E (TTM)–22.3
P/B1.93.9
P/E percentile vs own 5y5th8th
Dividend yield––
Revenue growth (YoY, latest qtr)+11.3%+41.2%
Net profit growth (YoY)+152.9%-1.4%
Gross margin56.2%97.7%
Operating margin7.6%24.6%
Net margin-2.9%19.0%
Return on equity-2.2%20.4%
Analyst target vs. price+20.1%+37.7%
Analyst buy share82%84%
RSI (14)5643
30-day volatility45.0%50.0%
Max drawdown, 1 year-26.2%-27.2%
Trend readStrong uptrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NBIX is the largest of the group by market value.
  • ELAN has returned the most over the past year.
  • NBIX is growing revenue fastest.
  • NBIX keeps the most profit per dollar of sales.
  • ELAN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top